Alphamab Oncology has dosed the first subject in the randomised Phase III JSKN003-306 trial of its anti-human epidermal ...

Biomedical concepts by CDISC are tailored to ensure data consistency, and link information throughout the data pipeline.

Spanish infrastructure manager Adif is tendering a contract to prepare a section of its 1000mm-gauge network for testing ...

Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.

General and Administration (G&A) expenses for the three months ended December 31, 2024 were $3.6 million USD, compared to $5.3 million USD for the same period in 2023. The decrease was primarily ...